# Scancell

Source: https://onco.cc/companies/scancell/  
OnCo record `scancell` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Scancell is a United Kingdom-based biotechnology company running 2 late-stage cancer trials in melanoma, triple-negative breast cancer and renal cell carcinoma.

## Summary

Scancell, based in Oxford, the United Kingdom, is a biotechnology company. Scancell is a late-stage clinical company developing active immunotherapies designed to enhance anti-tumour immune responses in cancer. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in melanoma, triple-negative breast cancer, renal cell carcinoma, ovarian cancer and head and neck squamous cell carcinoma. The largest, NCT04079166 (SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)), plans to enrol 173 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Scancell Ltd
- Tags: ctgov-sponsor
- HQ: Oxford
- Type: biotech
- Website: https://www.scancell.co.uk/

## Sources

- Official website: https://www.scancell.co.uk/
- ClinicalTrials.gov: trials led by Scancell: https://clinicaltrials.gov/search?lead=Scancell%20Ltd

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Melanoma](https://onco.cc/cancers/melanoma/), [Ovarian cancer](https://onco.cc/cancers/ovarian/), [Renal cell carcinoma](https://onco.cc/cancers/rcc/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- trials: [Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer](https://onco.cc/trials/nct05329532/), [SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)](https://onco.cc/trials/nct04079166/)

---
JSON: https://onco.cc/api/v1/entities/scancell.json